Unknown

Dataset Information

Bioavailability study of dronabinol oral solution versus dronabinol capsules in healthy volunteers.


ABSTRACT:

Background

Dronabinol, a pharmaceutical Δ-9-tetrahydrocannabinol, was originally developed as an oral capsule. This study evaluated the bioavailability of a new formulation, dronabinol oral solution, versus a dronabinol capsule formulation.

Methods

In an open-label, four-period, single-dose, crossover study, healthy volunteers were randomly assigned to one of two treatment sequences (T-R-T-R and R-T-R-T; T = dronabinol 4.25 mg oral solution and R = dronabinol 5 mg capsule) under fasted conditions, with a minimum 7-day washout period between doses. Analyses were performed on venous blood samples drawn 15 minutes to 48 hours postdose, and dronabinol concentrations were assayed by liquid chromatography-tandem mass spectrometry.

Results

Fifty-one of 52 individuals had pha

SUBMITTER: Parikh N 

PROVIDER: S-EPMC5066862 | biostudies-literature | 2016

REPOSITORIES: biostudies-literature